BCL2 and neoplasm: For this, we tested the molecular phenotypic markers, nuclear accumulation of p53 (p53nac) and expression of Bcl-2, in models without the tumor stage variable to assess their prognostic value and compared to the value of the tumor stage in predicting survival of CRC patients.